HM05636 | EPM2AIP1 | larynx | MESH:D001749 | Urinary Bladder Neoplasms | ureter |
HM05636 | EPM2AIP1 | larynx | MESH:D001749 | Urinary Bladder Neoplasms | bladder |
HM05636 | EPM2AIP1 | larynx | MESH:D008546 | Melanoma, Experimental | |
HM05636 | EPM2AIP1 | larynx | MESH:D011297 | Prenatal Exposure Delayed Effects | |
HM05636 | EPM2AIP1 | larynx | MESH:D014652 | Vascular Diseases | spinal cord |
HM05636 | EPM2AIP1 | larynx | MESH:D014652 | Vascular Diseases | lung |
HM05636 | EPM2AIP1 | larynx | MESH:D014652 | Vascular Diseases | liver |
HM05636 | EPM2AIP1 | larynx | MESH:D014652 | Vascular Diseases | kidney |
HM05636 | EPM2AIP1 | larynx | MESH:D014652 | Vascular Diseases | blood vessel |
HM05636 | EPM2AIP1 | larynx | MESH:D003924 | Diabetes Mellitus, Type 2 | pancreas |
HM05636 | EPM2AIP1 | larynx | MESH:D002318 | Cardiovascular Diseases | heart |
HM05636 | EPM2AIP1 | larynx | MESH:D002318 | Cardiovascular Diseases | bone marrow |
HM05636 | EPM2AIP1 | larynx | MESH:D002318 | Cardiovascular Diseases | blood vessel |
HM05636 | EPM2AIP1 | larynx | MESH:D004489 | Edema, Cardiac | |
HM05636 | EPM2AIP1 | larynx | MESH:D019046 | Bone Marrow Neoplasms | |
HM05636 | EPM2AIP1 | larynx | MESH:D002252 | Carbon Tetrachloride Poisoning | |
HM05636 | EPM2AIP1 | larynx | MESH:D008107 | Liver Diseases | skin |
HM05636 | EPM2AIP1 | larynx | MESH:D008107 | Liver Diseases | muscle |
HM05636 | EPM2AIP1 | larynx | MESH:D008107 | Liver Diseases | lung |
HM05636 | EPM2AIP1 | larynx | MESH:D008107 | Liver Diseases | liver |
HM05636 | EPM2AIP1 | larynx | MESH:D000014 | Abnormalities, Drug-Induced | |
HM05636 | EPM2AIP1 | larynx | MESH:D000740 | Anemia | bone marrow |
HM05636 | EPM2AIP1 | larynx | MESH:D000799 | Angioedema | skin |
HM05636 | EPM2AIP1 | larynx | MESH:D017488 | Hyperkeratosis, Epidermolytic | |
HM05636 | EPM2AIP1 | larynx | MESH:D007569 | Jaw Abnormalities | |
HM05636 | EPM2AIP1 | larynx | MESH:D004362 | Drug Toxicity | |
HM05636 | EPM2AIP1 | larynx | MESH:D012512 | Sarcoma, Ewing's | |
HM05636 | EPM2AIP1 | larynx | MESH:D056487 | Drug-Induced Liver Injury, Chronic | liver |
HM05636 | EPM2AIP1 | larynx | MESH:D050197 | Atherosclerosis | kidney |
HM05636 | EPM2AIP1 | larynx | MESH:D050197 | Atherosclerosis | heart |
HM05636 | EPM2AIP1 | larynx | MESH:D050197 | Atherosclerosis | blood vessel |
HM05636 | EPM2AIP1 | larynx | MESH:D002294 | Carcinoma, Squamous Cell | lung |
HM05636 | EPM2AIP1 | larynx | MESH:D002294 | Carcinoma, Squamous Cell | liver |
HM05636 | EPM2AIP1 | larynx | MESH:D002294 | Carcinoma, Squamous Cell | larynx |
HM05636 | EPM2AIP1 | larynx | MESH:D002294 | Carcinoma, Squamous Cell | kidney |
HM05636 | EPM2AIP1 | larynx | MESH:D002294 | Carcinoma, Squamous Cell | eye |
HM05636 | EPM2AIP1 | larynx | MESH:D008113 | Liver Neoplasms | |
HM05636 | EPM2AIP1 | larynx | MESH:D008113 | Liver Neoplasms | |
HM05636 | EPM2AIP1 | larynx | MESH:D018281 | Cholangiocarcinoma | liver |
HM05636 | EPM2AIP1 | larynx | MESH:D005234 | Fatty Liver | |
HM05636 | EPM2AIP1 | larynx | MESH:D007674 | Kidney Diseases | ureter |
HM05636 | EPM2AIP1 | larynx | MESH:D007674 | Kidney Diseases | pituitary |
HM05636 | EPM2AIP1 | larynx | MESH:D007674 | Kidney Diseases | kidney |
HM05636 | EPM2AIP1 | larynx | MESH:D008106 | Liver Cirrhosis, Experimental | |
HM05636 | EPM2AIP1 | larynx | MESH:D010146 | Pain | |
HM05636 | EPM2AIP1 | larynx | MESH:D054079 | Vascular Malformations | |
HM05636 | EPM2AIP1 | larynx | MESH:D006930 | Hyperalgesia | |
HM05636 | EPM2AIP1 | larynx | MESH:D017119 | Porphyria Cutanea Tarda | skin |
HM05636 | EPM2AIP1 | larynx | MESH:D012878 | Skin Neoplasms | |
HM05636 | EPM2AIP1 | larynx | MESH:D001321 | Autistic Disorder | |
HM05636 | EPM2AIP1 | larynx | MESH:D014581 | Urticaria | skin |
HM05636 | EPM2AIP1 | larynx | MESH:D006973 | Hypertension | lung |
HM05636 | EPM2AIP1 | larynx | MESH:D006973 | Hypertension | heart |
HM05636 | EPM2AIP1 | larynx | MESH:D006973 | Hypertension | blood vessel |
HM05636 | EPM2AIP1 | larynx | MESH:D007642 | Keratosis | skin |
HM05636 | EPM2AIP1 | larynx | MESH:D017114 | Liver Failure, Acute | |
HM05636 | EPM2AIP1 | larynx | MESH:D056486 | Drug-Induced Liver Injury | |
HM05636 | EPM2AIP1 | larynx | MESH:D017093 | Liver Failure | |
HM05636 | EPM2AIP1 | larynx | MESH:D013959 | Thyroid Diseases | thyroid |
HM05636 | EPM2AIP1 | larynx | MESH:D006932 | Hyperbilirubinemia | |
HM05636 | EPM2AIP1 | larynx | MESH:D010190 | Pancreatic Neoplasms | pancreas |
HM05636 | EPM2AIP1 | larynx | MESH:D006332 | Cardiomegaly | |
HM05636 | EPM2AIP1 | larynx | MESH:D018246 | Adrenocortical Adenoma | |
HM05636 | EPM2AIP1 | larynx | MESH:D004487 | Edema | |
HM05636 | EPM2AIP1 | larynx | MESH:D006470 | Hemorrhage | |
HM05636 | EPM2AIP1 | larynx | MESH:D008114 | Liver Neoplasms, Experimental | |
HM05636 | EPM2AIP1 | larynx | MESH:D016491 | Peripheral Vascular Diseases | |
HM05636 | EPM2AIP1 | larynx | MESH:D019465 | Craniofacial Abnormalities | |
HM05636 | EPM2AIP1 | larynx | MESH:D017202 | Myocardial Ischemia | heart |
HM05636 | EPM2AIP1 | larynx | MESH:D015619 | Respiratory System Abnormalities | |
HM05636 | EPM2AIP1 | larynx | MESH:D005534 | Foot Diseases | |
HM05636 | EPM2AIP1 | larynx | MESH:D024801 | Tauopathies | nerve |
HM05636 | EPM2AIP1 | larynx | MESH:D006330 | Heart Defects, Congenital | |
HM05636 | EPM2AIP1 | larynx | MESH:D005313 | Fetal Death | |
HM05636 | EPM2AIP1 | larynx | MESH:D006505 | Hepatitis | |
HM05636 | EPM2AIP1 | larynx | MESH:D002280 | Carcinoma, Basal Cell | |
HM05636 | EPM2AIP1 | larynx | MESH:D006529 | Hepatomegaly | |
HM05636 | EPM2AIP1 | larynx | MESH:D006689 | Hodgkin Disease | |
HM05636 | EPM2AIP1 | larynx | MESH:D010382 | Peliosis Hepatis | liver |
HM05636 | EPM2AIP1 | larynx | MESH:D002386 | Cataract | pancreas |
HM05636 | EPM2AIP1 | larynx | MESH:D002386 | Cataract | eye |
HM05636 | EPM2AIP1 | larynx | MESH:D001836 | Body Weight Changes | |
HM05636 | EPM2AIP1 | larynx | MESH:D001778 | Blood Coagulation Disorders | bone marrow |
HM05636 | EPM2AIP1 | larynx | MESH:D002340 | Carotid Artery Diseases | blood vessel |
HM05636 | EPM2AIP1 | larynx | MESH:D005355 | Fibrosis | |
HM05636 | EPM2AIP1 | larynx | MESH:D006561 | Herpes Simplex | |
HM05636 | EPM2AIP1 | larynx | MESH:D008103 | Liver Cirrhosis | liver |
HM05636 | EPM2AIP1 | larynx | MESH:D020078 | Neurogenic Inflammation | |
HM05636 | EPM2AIP1 | larynx | MESH:D000013 | Congenital Abnormalities | |
HM05636 | EPM2AIP1 | larynx | MESH:D001943 | Breast Neoplasms | breast |
HM05636 | EPM2AIP1 | larynx | MESH:D002295 | Carcinoma, Transitional Cell | |
HM05636 | EPM2AIP1 | larynx | MESH:D001848 | Bone Diseases, Developmental | |
HM05636 | EPM2AIP1 | larynx | MESH:D015473 | Leukemia, Promyelocytic, Acute | |
HM05636 | EPM2AIP1 | larynx | MESH:D008223 | Lymphoma | |
HM05636 | EPM2AIP1 | larynx | MESH:D006869 | Hydronephrosis | kidney |
HM05636 | EPM2AIP1 | larynx | MESH:D007249 | Inflammation | |
HM05636 | EPM2AIP1 | larynx | MESH:D008175 | Lung Neoplasms | lung |
HM05636 | EPM2AIP1 | larynx | MESH:D011471 | Prostatic Neoplasms | prostate |
HM05636 | EPM2AIP1 | larynx | MESH:D018248 | Adenoma, Liver Cell | |
HM05636 | EPM2AIP1 | larynx | MESH:D009436 | Neural Tube Defects | |
HM05636 | EPM2AIP1 | larynx | MESH:D012871 | Skin Diseases | skin |
HM05636 | EPM2AIP1 | larynx | MESH:D002972 | Cleft Palate | |
HM05636 | EPM2AIP1 | larynx | MESH:D006528 | Carcinoma, Hepatocellular | liver |
HM05636 | EPM2AIP1 | larynx | MESH:D010051 | Ovarian Neoplasms | uterus |
HM05636 | EPM2AIP1 | larynx | MESH:D010051 | Ovarian Neoplasms | |
HM05636 | EPM2AIP1 | larynx | MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | |
HM05636 | EPM2AIP1 | larynx | MESH:D002277 | Carcinoma | |
HM05636 | EPM2AIP1 | larynx | MESH:D009421 | Nervous System Malformations | |
HM05636 | EPM2AIP1 | larynx | MESH:D020261 | Arsenic Poisoning | |
HM05636 | EPM2AIP1 | larynx | MESH:D005124 | Eye Abnormalities | |
HM05636 | EPM2AIP1 | larynx | MESH:D019282 | Wasting Syndrome | |
HM05636 | EPM2AIP1 | larynx | MESH:D019636 | Neurodegenerative Diseases | nerve |